Another week on the U.S. stock market is starting with mixed sentiment. US100 is up by about 0.2–0.3% at the start of the session, US500 stays flat, US2000 suffers decline of aprox. 0,7%.
At the moment, the market is seeing a clash between an untiring positive trend focused on technology companies and increasingly audible skeptical voices, supported by news from the Middle East.
Despite market sentiment suggesting that a peace declaration between the U.S. and Iran has effectively been signed or will be signed soon, the situation remains unclear. The ceasefire is still fragile, and the strategically important Strait of Hormuz remains closed. Just last night, CENTCOM confirmed an Iranian attack on U.S. facilities in Kuwait.
Macroeconomic data
In the U.S., ISM and PMI data from the manufacturing sector will be released.
- The market expects the producer prices index to rise to 55.3 in May.
- The main ISM manufacturing index is expected to increase to 53 points.
US100 (D1)
The index has maintained strong upward momentum since breaking out from a local low in March. RSI remains elevated, MACD is normalizing, but the EMA structure remains clearly bullish. The key resistance is the 23.6% Fibonacci retracement (~30,485), while the first support for buyers is around ~29,730. If the 23.6% Fibonacci level is broken in the near term, the next target for buyers will be the area around 31,755 points. Source: xStation5
Company news
- Software companies: Nvidia CEO Jensen Huang noted in one of his statements that the software sector is not at as much risk from AI as some may think. Strong gains can be observed across the market. Leaders include ServiceNow (NOW.US), Salesforce (CRM.US), Adobe (ADBE.US), Workday (WDAY.US), and Palantir (PLTR.US).
- Nvidia (NVDA.US), Qualcomm (QCOM.US): Qualcomm is down about 7%, Nvidia is up just under 2%, and ARM is gaining more than 13% following Nvidia’s new product presentations. Investors are expressing concerns about competition for the “Snapdragon” product line.
- Revolution Medicines (RVMD.US): The company is up about 10% after presenting research results on a new pancreatic cancer drug.
- Taylor Morrison Home Corp. (TMHC.US): The construction company is up about 20% after Berkshire Hathaway decided to purchase the company for $8.5 billion.
- IBM (IBM.US): The stock is up about 8%. Bloomberg News attributes the rise to a new video in which Donald Trump reportedly speaks positively about the company’s CEO.
Oil on hold as the market bets on diplomacy
Morning Briefing: Inconsistent messages ahead of key data (02.06.2026)
Daily summary: Tech sector holds valuations despite risk
Robinhood under the Supreme Court's Eye
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.